Clinical Trial Update: Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage [Phase 3]

View source ↗

Summary

Phase 3 clinical trial studying SHR-1209 for primary hypercholesterolemia and mixed hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Hyperlipidemia

Drugs mentioned

• SHR-1209

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Primary Hypercholesterolemia, Mixed Hyperlipemia | Phase 3 | Status: COMPLETED